Remifemin

Remifemin

Manufacturer:

Schaper & Brummer

Distributor:

Pahang Pharmacy
Full Prescribing Info
Contents
Cimicifuga racemosa rhizome extract.
Description
The active substance is dry extract of Cimicifuga rhizome.
1 tablet contains 2.5 mg dry extract of Cimicifugae racemosae (L.) Nutt. rhizoma (6-11:1).
Extraction solvent: isopropyl alcohol 40 % (v/v).
Excipients/Inactive Ingredients: cellulose powder, lactose monohydrate, potato starch, magnesium stearate (vegetable).
Indications/Uses
Traditionally used to relieve symptoms of menopause such as hot flushes and profuse sweating.
Dosage/Direction for Use
Always take this medicine exactly as described as follows or as per doctor's instruction. Check with the doctor or pharmacist if the patient is not sure.
The recommended dose is: Adult: 1 tablet twice a day - one in the morning and one in the evening - with no special regard to meals.
Swallow as whole with sufficient liquid. Do not suck or chew the tablet.
The score line is not intended for breaking the tablet.
Due to the indication, a use by children, adolescents or men is not intended.
There are no adequate data for specific dosage recommendations in case of impaired renal/liver function.
Duration of treatment: If the symptoms persist during the use of the medicine, the patient should consult a doctor or pharmacist.
Remifemin does not reveal its action immediately. First therapeutic effects can be seen after two weeks of treatment at the earliest. It is advisable to take Remifemin for several months, but not longer than six months without medical advice.
If the patient take more Remifemin: The listed side effects may be more severe. Patient should then stop taking the medicine and see a doctor.
If none of these side effects occur, continue taking the usual dose at the usual time.
If the patient forgets to take Remifemin: Do not take a double dose to make up for a forgotten tablet. Continue the intake at the usual time.
If the patient have any further questions on the use of this medicine, ask the doctor or pharmacist.
Contraindications
Do not take Remifemin if the patient is allergic to Cimicifuga rhizome or to any of the other ingredients of this medicine (listed in Description).
Special Precautions
This is a traditional medicine.
Consult the pharmacist/doctor if symptoms persist/worsen
Patients using herbal medicinal products should tell the doctor about it.
Talk to the doctor before taking Remifemin if the patient had or have liver injury; if patient is taking oestrogens concurrently; if patients have been treated or undergoing treatment for breast cancer or other hormone-dependent tumours.
Stop taking this product if signs and symptoms suggestive of liver injury develop such as tiredness, loss of appetite, yellowing of the skin and eyes or severe upper stomach pain with nausea and vomiting or dark urine and consult the doctor immediately.
If vaginal bleeding occurs or other symptoms occur, a doctor should be consulted.
Remifemin contains lactose (milk sugar): If the patient has been told by the doctor that she/he has an intolerance to some sugars, contact the doctor before taking this medicinal product.
Driving and using machines: No studies on the effect on the ability to drive and use machines have been performed.
Use In Pregnancy & Lactation
Pregnancy and breastfeeding: Contraindicated in pregnant women. Insufficient reliable data in breastfeeding women.
Women of child-bearing potential should consider using effective contraception during treatment.
Side Effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Possible side effects: With the use of this medicinal product, following side effects may occur: Rare (may affect up to 1 in 1000 people): Face swelling or peripheral swelling, allergic skin reactions (urticaria, pruritis, skin rash), gastrointestinal disorders (dyspepsia (digestive problems), diarrhoea).
Frequency not known (cannot be estimated from the available data): There are reports of liver toxicity with Cimicifuga containing products (hepatitis, jaundice, abnormal results of liver tests).
In these cases stop taking the medicine and consult the doctor.
Drug Interactions
Unknown.
Storage
Store below 30°C. Protect from light and moisture.
MIMS Class
Supplements & Adjuvant Therapy
ATC Classification
G02CX04 - Cimicifugae rhizoma ; Belongs to the class of other gynecologicals. Used in the treatment of menopausal symptoms.
Presentation/Packing
Tab 2.5 mg (white to beige, round, slightly biconvexed, with one sided decorative score line) x 4 x 15's.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in